PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsPrasco
Prasco
Prasco is a pharmaceutical company headquartered in Cincinnati, Ohio, and founded in 2002 by E. Thomas Arington, former Chairman and CEO of Duramed Pharmaceuticals and former president of the healthcare consulting firm MarketMaster. The company remains privately held. It specializes in the field of authorized generics, generic drugs manufactured by the branded innovator company but marketed under a private label. According to IMS Health, the pharmaceutical industry auditing service, Prasco is one of the fastest growing pharmaceutical companies in the industry, in terms of relative growth and prescriptions dispensed for the years 2005 and 2006. Although it does not release financial data, $150 million in sales were tracked by an independent consulting company during 2005, reportedly doubling the previous years' figures.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
DexamethasoneDexamethasone1982-01-012023-2039
EplerenoneEplerenone2017-02-02
EstradiolEstradiol2021-07-152024-2037
FluphenazineFluphenazine1988-08-12
Sulfamethoxazole trimethoprimSulfamethoxazole, Trimethoprim2006-11-13
MirtazapineMirtazapine2023-01-18
DextroamphetamineDextroamphetamine2008-01-292023-2042
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Estradiol
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use